12
Participants
Start Date
January 31, 2022
Primary Completion Date
January 31, 2023
Study Completion Date
August 31, 2023
Bacteriophage cocktail spray
Study intervention consists of a dosage-metered airless spray containing a cocktail of 14 bacteriophages at a concentration of 1.4 x 10\^8 PFU/mL for an effective dosage of 2.5 x10\^5 PFU/cm\^2 of burned area. The study intervention will be applied in conjunction with standard of care.
Xeroform
Standard of care will consist of Xeroform primary dressing and Kenacomb topical antibiotic cream (for wounds with signs of localized infection)
Lead Sponsor
Precisio Biotix Therapeutics, Inc.
INDUSTRY